Difference between revisions of "Team:MIT"

Line 15: Line 15:
 
                     <img src="https://static.igem.org/mediawiki/2017/9/9c/MIT-Logo.jpg" alt="iGEM logo" class="logo">
 
                     <img src="https://static.igem.org/mediawiki/2017/9/9c/MIT-Logo.jpg" alt="iGEM logo" class="logo">
 
                     <ul class="main-nav nav-text">
 
                     <ul class="main-nav nav-text">
                         <li><a href="#">Home</a></li>
+
                         <li><a href="https://2017.igem.org/Team:MIT">Home</a></li>
 
                         <li><a href="https://2017.igem.org/Team:MIT/team">About Us</a></li>
 
                         <li><a href="https://2017.igem.org/Team:MIT/team">About Us</a></li>
 
                         <li><a href="https://2017.igem.org/Team:MIT/project">Project</a></li>
 
                         <li><a href="https://2017.igem.org/Team:MIT/project">Project</a></li>

Revision as of 16:28, 27 August 2017

MIT iGEM 2017

Artificial Control of
Alternative Splicing

Background Show me how

What is Alternative splicing?

Alternative splicing is a process that takes mRNA transcripts and modifies it in various ways to create a final mature mRNA molecule for translation. Some sequences known as introns are removed; other sequences known as exons remain to be translated. With such a process, a single gene can result in many types of proteins transcripts

Our iGEM projects seeks to control alternative splicing of RNA, specifically exon skipping and inclusion, using a protein called Cas13a. This is a protein that attaches to RNA via a complementary guide RNA, then cuts the RNA strand. For our purposes, we're using a modified version of this protein, known as dCas13a, that can attach, but doesn't cut. By targeting certain portions of a fluorescent protein construct, we can determine whether or not we achieved the intended isoforms based on the presence or absence of the fluorescent protein in addition to sequencing.